Abstract
Systemic lupus erythematosus The current treatment approach of SLE includes the use of antimalarials, immunosuppressive drugs, steroids and nonsteroidal agents. The development of new biotherapies that target both the immune cells and cytokine pathways has resulted in a radical change in the management strategy of SLE. Several abstracts addressed the use of immunosuppressive agents, while presentations on new biological therapies provided insights into the changing therapeutic landscape.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
